10th R&D Procurement and Sourcing in Pharma Summit

R&D procurement is undergoing a structural shift, from transactional buying toward strategic, innovation-driven value creation across the development pipeline, and the 10th R&D Procurement and Sourcing in Pharma Summit brings that transition into focus for senior procurement leaders.

How the summit frames AI, CRO value, and global sourcing complexity

The programme addresses three converging pressures the source identifies explicitly: strengthening global sourcing models amid geopolitical instability, extracting measurable value from CRO and CMO partnerships, and deploying AI and strategic initiatives to accelerate study timelines. The event's stated ambition is to help organisations establish procurement excellence in service of R&D innovation, a scope that spans supplier governance, pipeline strategy, and operational efficiency.

What procurement heads running CRO and CMO portfolios should weigh

For procurement directors managing external development relationships, the summit's focus on moving beyond transactional models is directly relevant to contract strategy and supplier performance frameworks. The geopolitical sourcing thread will carry particular weight for teams reconfiguring supply networks in response to regulatory and trade-environment shifts. Read against current pressures on clinical timelines, the AI-and-strategic-initiatives strand offers a practical lens for teams evaluating where automation can reduce cycle time without adding vendor risk.

Registration details are available via the event website; this is the tenth edition of the summit, signalling an established annual series within the pharma procurement community.